Washington University School of Medicine
St Louis, Missouri, 63110, United States
NCT Number: NCT05470218
High protein low carbohydrate diets have become popular in recent years to help facilitate weight loss. It is controversial if these diets are associated with an increased risk of cardiovascular disease. Recent work in mice has implicated monocytes/macrophages and mTOR signaling as the culprit cell type driving the increased cardiovascular risk with high protein diets. We aim to build on this preclinical research by evaluating the effects of liquid meals with different protein and leucine (a potent mTOR activator) contents on circulating human monocytes and platelets. Study participants will be given either a low protein liquid meal, a high protein liquid meal, or a low protein liquid meal with additional leucine. Blood will be collected from study participants just just prior to and for several hours after ingestion of the meals. Activation of amino acid-dependent signaling pathways (particularly mTOR) and downstream sequelae will be evaluated in the isolated monocytes and platelets.
This study is active but is not currently recruiting participants.
18 year–95 year
All sexes
Interventional
Not applicable
St Louis, Missouri, 63110, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Liquid mixed meal with different amounts of protein and leucine
Time frame: change from before meal at 1 hour and 3 hours, compared to before
University of Missouri-Columbia
Other
Protein, Platelet, and Monocyte
Acronym: HPL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06590012
Arterial Occlusive Diseases, Arteriosclerosis
Kazan', Russia
View Trial DetailsNCT06692127
Arterial Occlusive Diseases, Arteriosclerosis
Copenhagen, Denmark
View Trial DetailsNCT06013722
Acute Coronary Syndrome, Arterial Occlusive Diseases
Monaco
View Trial DetailsNCT06198920
Arterial Occlusive Diseases, Arteriosclerosis
San Donato Milanese, Milan, Italy
View Trial Details